Effects of
ganoderic acid A (GAA), a lanostane
triterpene, on
hypoxia-
ischemia encephalopathy (HIE) remain unclear. We aimed to figure out the specific role of GAA in
hypoxia-treated neural stem cells (NSCs) as well as the regulatory mechanisms. Primary rat NSCs were incubated under
hypoxia to simulate HIE. Viability and apoptosis of
hypoxia-injured NSCs were measured by cell counting kit-8 and flow cytometry assays, respectively.
Proteins related to apoptosis, autophagy, and the PI3K/AKT/mTOR pathways were evaluated by Western blot analysis.
LY294002 and
rapamycin were added to inhibit the PI3K/AKT pathway and mTOR pathway, respectively.
Enzyme-linked
immunosorbent assay was carried out to test the release of proinflammatory
cytokines. We found that
hypoxia-induced decrease of cell viability, increases of apoptotic cells and autophagy, and the release of
IL-6, IL-1β, and TNF-α were all attenuated by GAA stimulation. Activation of
caspases induced by
hypoxia was alleviated by GAA. Furthermore, we found that inhibition of the PI3K/AKT pathway eliminated the effects of GAA on apoptosis and proinflammatory
cytokines release in
hypoxia-injured NSCs. Meanwhile, inhibition of the mTOR pathway abrogated the effects of GAA on cell autophagy in
hypoxia-injured NSCs. In conclusion, GAA alleviated
hypoxia-induced injury in NSCs might be through activating the PI3K/AKT and mTOR pathways.